NEWS
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
Press Release: Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Category: Business News
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders. Upon completion of the acquisition, pursuant to the […]
Source: Bristol-Myers Squibb
More
The Top-50 biopharmaceutical investors in the world.
Category: Health
The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D. The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn […]
Source: Health Informatics
More
Bristol-Myers kjøper Celgene for 647 milliarder kroner
Category: Health
Legemiddelselskapet Bristol-Myers Squibb har inngått en avtale om å kjøpe opp bioteknologiselskapet Celgene i en avtale verdt rundt 74 milliarder dollar, tilsvarende 647 milliarder kroner. Det skriver Bristol-Myers i en børsmelding. Til sammenligning er Norges mest verdifulle selskap, Equinor, verdt 629 milliarder kroner torsdag ettermiddag. Avtalen innebærer at aksjonærene i Celgene får en aksje i […]
Source: E24
More
Abbvie: Helsenæring
Category: Government
AmCham members Abbvie recently launched a magazine highlighting the advantages of an expanded and innovative research-based health industry in Norway.
Source: Abbvie
More
Trenger vi en sterk norsk innovasjonsbasert helsenæring?
Category: Health
Hvis man skal kåre et nytt trendord i 2018 ville jeg foreslått «Helsenæring». Det var et tema som gikk igjen under årets Arendalsuke og det er ingen tvil om at det er stort fokus på å bygge en sterk helsenæring i Norge. Regjeringen skal ha mye av æren for dette og det er forventet at […]
Source: Dagens Medisin
More